Asian Spectator


The Times

.

Kazia Therapeutics Strengthens Scientific Leadership with Appointment of Dr. Sudha Rao as Chief Scientific Officer to Lead Next-Generation Oncology Platform

  • Written by PR Newswire Asia - Asian Spectator

SYDNEY, April 15, 2026 /PRNewswire/ -- Kazia Therapeutics (NASDAQ: KZIA), a clinical-stage oncology company developing differentiated therapies for cancers with high unmet need, today announced the appointment of Dr. Sudha Rao as Chief Scientific Officer (CSO).

Dr. Rao is the scientific originator of the epigenetic framework underlying paxalisib...

Magazine

What to Consider Before Choosing a Cardboard Box Manufacturer

Start With the Packaging Purpose The right packaging begins with a clear understanding of what the box needs to do. A cardboard box manufacturer can help translate requirements such as product prot...

Why Emotional Battles Drain Your Wealth During Separation

Navigating a marriage ending is fundamentally a structural transition, not just an emotional event. When you approach separation with a clear roadmap, you protect your long term financial stability ...

How Long Does Botox Really Last? A Realistic Timeline

Someone might notice a line between their eyebrows getting deeper after a stressful week, or catch their forehead creasing in a video call in a way it did not before. It is a small observation, easy...

hacklink StreamEastzlibraryzlibraryzlibrarycasibombahisfair resmi girişcasibom günceljustin tvjojobetjojobetjojobetPorno siteleri HDPadişahbetGalabetStreamEast1xbet giriştipobet resmi girişjojobetcasino sitelericasibomcasibomPadişahbetGalabetVipparkmarsbahistaraftarium24vippark girisjojobetdeneme bonusu